Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 35 of 35 entries
View as:

Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults

Phase: N/A Priority: Normal
NCT ID: NCT03154515 Org: User:
Start: 01/31/10 End: 10/31/14 Due: 10/31/15

Efficacy and Safety of Dioxidin Versus Miramistin in Superficial Pyoderma

Phase: N/A Priority: Normal
NCT ID: NCT05561816 Org: User:
Start: 07/19/22 End: 12/20/22 Due: 12/20/23

Efficacy and Safety of Ranquilon in Patients With Anxiety Disorders Due to Neurasthenia and Adaptation Disorders

Phase: N/A Priority: Normal
NCT ID: NCT06843044 Org: User:
Start: 01/13/25 End: 12/31/27 Due: 12/31/28

A Study to Evaluate the Safety, Tolerability and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections

Phase: N/A Priority: Normal
NCT ID: NCT05030324 Org: User:
Start: 10/01/21 End: 05/04/22 Due: 05/04/23

Study of the Effect of Food Intake on the Bioavailability of XC221 100 mg Tablets

Phase: N/A Priority: Normal
NCT ID: NCT05295121 Org: User:
Start: 02/10/22 End: 03/17/22 Due: 03/17/23

Safety, Tolerability and Pharmacokinetics of 4-MUST, Tablets, 128 mg (Valenta Pharm JSC) During Single and Multiple Oral Administration in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06315387 Org: User:
Start: 12/04/23 End: 12/31/24 Due: 12/31/25

Pharmacokinetics and Bioequivalence of Doxylamine + Pyridoxine, Film-coated, Enteric-soluble Tablets, and Diclectin, Delayed Release Tablets, in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05498233 Org: User:
Start: 08/18/22 End: 09/19/22 Due: 09/19/23

Efficacy and Safety Study of Ingavirin® to Treat Influenza and Other Acute Respiratory Viral Infections in Patients 3-6 y.o.

Phase: N/A Priority: Normal
NCT ID: NCT02644018 Org: User:
Start: 01/31/16 End: 05/31/16 Due: 05/31/17

Safety, Tolerability, and Pharmacokinetic Parameters of Grammidin, a Metered Spray in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06859281 Org: User:
Start: 12/10/24 End: 12/01/26 Due: 12/01/27

Safety, Tolerability, and Pharmacokinetic Parameters of Increasing Doses of Ingavirin Forte, Capsules, During Single and Subsequent Multiple Oral Administration in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06859333 Org: User:
Start: 01/13/25 End: 12/31/25 Due: 12/31/26